The relevance of tick bites to the production of IgE antibodies to the mammalian oligosaccharide galactose-α-1,3-galactose
- PMID: 21453959
- PMCID: PMC3085643
- DOI: 10.1016/j.jaci.2011.02.019
The relevance of tick bites to the production of IgE antibodies to the mammalian oligosaccharide galactose-α-1,3-galactose
Abstract
Background: In 2009, we reported a novel form of delayed anaphylaxis to red meat that is related to serum IgE antibodies to the oligosaccharide galactose-α-1,3-galactose (alpha-gal). Most of these patients had tolerated meat for many years previously. The implication is that some exposure in adult life had stimulated the production of these IgE antibodies.
Objectives: We sought to investigate possible causes of this IgE antibody response, focusing on evidence related to tick bites, which are common in the region where these reactions occur.
Methods: Serum assays were carried out with biotinylated proteins and extracts bound to a streptavidin ImmunoCAP.
Results: Prospective studies on IgE antibodies in 3 subjects after tick bites showed an increase in levels of IgE to alpha-gal of 20-fold or greater. Other evidence included (1) a strong correlation between histories of tick bites and levels of IgE to alpha-gal (χ(2) = 26.8, P < .001), (2) evidence that these IgE antibodies are common in areas where the tick Amblyomma americanum is common, and (3) a significant correlation between IgE antibodies to alpha-gal and IgE antibodies to proteins derived from A americanum (r(s) = 0.75, P < .001).
Conclusion: The results presented here provide evidence that tick bites are a cause, possibly the only cause, of IgE specific for alpha-gal in this area of the United States. Both the number of subjects becoming sensitized and the titer of IgE antibodies to alpha-gal are striking. Here we report the first example of a response to an ectoparasite giving rise to an important form of food allergy.
Copyright © 2011 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.
Figures




Similar articles
-
Delayed anaphylaxis to red meat in patients with IgE specific for galactose alpha-1,3-galactose (alpha-gal).Curr Allergy Asthma Rep. 2013 Feb;13(1):72-7. doi: 10.1007/s11882-012-0315-y. Curr Allergy Asthma Rep. 2013. PMID: 23054628 Free PMC article. Review.
-
Tick bites, IgE to galactose-alpha-1,3-galactose and urticarial or anaphylactic reactions to mammalian meat: The alpha-gal syndrome.Allergy. 2024 Jun;79(6):1440-1454. doi: 10.1111/all.16003. Epub 2024 Jan 9. Allergy. 2024. PMID: 38193233 Free PMC article. Review.
-
Delayed anaphylaxis, angioedema, or urticaria after consumption of red meat in patients with IgE antibodies specific for galactose-alpha-1,3-galactose.J Allergy Clin Immunol. 2009 Feb;123(2):426-33. doi: 10.1016/j.jaci.2008.10.052. Epub 2008 Dec 13. J Allergy Clin Immunol. 2009. PMID: 19070355 Free PMC article.
-
Anaphylaxis to the carbohydrate side chain alpha-gal.Immunol Allergy Clin North Am. 2015 May;35(2):247-60. doi: 10.1016/j.iac.2015.01.009. Epub 2015 Mar 6. Immunol Allergy Clin North Am. 2015. PMID: 25841549 Free PMC article. Review.
-
The Immunology of Alpha-Gal Syndrome: History, Tick Bites, IgE, and Delayed Anaphylaxis to Mammalian Meat.Immunol Rev. 2025 Jul;332(1):e70035. doi: 10.1111/imr.70035. Immunol Rev. 2025. PMID: 40515672 Free PMC article. Review.
Cited by
-
Pathogenesis, newly recognized etiologies, and management of idiopathic anaphylaxis.Discov Med. 2015 Feb;19(103):137-44. Discov Med. 2015. PMID: 25725228 Free PMC article. Review.
-
Immunotherapy with biodegradable nanoparticles encapsulating the oligosaccharide galactose-alpha-1,3-galactose enhance immune tolerance against alpha-gal sensitization in a murine model of alpha-gal syndrome.Front Allergy. 2024 Aug 9;5:1437523. doi: 10.3389/falgy.2024.1437523. eCollection 2024. Front Allergy. 2024. PMID: 39183976 Free PMC article.
-
Serum IgE against galactose-alpha-1,3-galactose is common in Laotian patients with snakebite envenoming but not the major trigger for early anaphylactic reactions to antivenom.Toxicon X. 2020 Jul 28;7:100054. doi: 10.1016/j.toxcx.2020.100054. eCollection 2020 Sep. Toxicon X. 2020. PMID: 32776003 Free PMC article.
-
Cross-reactive and pre-existing antibodies to therapeutic antibodies--Effects on treatment and immunogenicity.MAbs. 2015;7(4):662-71. doi: 10.1080/19420862.2015.1048411. MAbs. 2015. PMID: 25962087 Free PMC article. Review.
-
IgE to galactose-α-1,3-galactose wanes over time in patients who avoid tick bites.J Allergy Clin Immunol Pract. 2020 Jan;8(1):364-367.e2. doi: 10.1016/j.jaip.2019.08.045. Epub 2019 Sep 11. J Allergy Clin Immunol Pract. 2020. PMID: 31520841 Free PMC article. No abstract available.
References
-
- Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med. 2006;354:567–78. - PubMed
-
- Cunningham D, Humblet Y, Siena S, Khayat D, Bleiberg H, Santoro A, et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med. 2004;351:337–45. - PubMed
-
- O'Neil BH, Allen R, Spigel DR, Stinchcombe TE, Moore DT, Berlin JD, et al. High incidence of cetuximab-related infusion reactions in Tennessee and North Carolina; association with atopic history. J Clin Oncol. 2007;25:2644–8. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical